CORRESP Filing
iBio, Inc. (IBIO) (CIK 0001420720)
Date: March 4, 2026 · CIK: 0001420720 · Accession: 0001104659-26-023517
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293864
Letter
VIA EDGAR United States Securities Division of Corporation Finance Attention: Tyler Howes Re: iBio, Inc. Registration Statement on Form S-3 Filed February 27, 2026 File No: 333-293864
Dear Mr. Howes:
iBio, Inc. (the “Registrant”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-293864), be accelerated by the U.S. Securities and Exchange Commission (the “Commission”) to become effective on Friday, March 6, 2026, at 5:00 p.m., Eastern Time, or as soon as reasonably practicable thereafter.
The Registrant understands that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes Leslie Marlow or Melissa Palat Murawsky of Blank Rome LLP to orally modify or withdraw this request for acceleration. Please contact Leslie Marlow at (212) 885-5358 or Melissa Palat Murawsky at (215) 569-5732 with any questions you may have concerning this request, and please notify either of them when this request for acceleration has been granted.
Very truly yours,
IBIO, INC.
Show Raw Text
CORRESP
1
filename1.htm
March 4, 2026
VIA EDGAR
United States Securities
and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tyler Howes
Re:
iBio, Inc.
Registration Statement on Form S-3
Filed February 27, 2026
File No: 333-293864
Dear Mr. Howes:
iBio, Inc. (the “Registrant”)
hereby requests that the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-293864), be accelerated
by the U.S. Securities and Exchange Commission (the “Commission”) to become effective on Friday, March 6, 2026,
at 5:00 p.m., Eastern Time, or as soon as reasonably practicable thereafter.
The Registrant understands
that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities
under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes
Leslie Marlow or Melissa Palat Murawsky of Blank Rome LLP to orally modify or withdraw this request for acceleration. Please contact Leslie
Marlow at (212) 885-5358 or Melissa Palat Murawsky at (215) 569-5732 with any questions you may have concerning this request, and please
notify either of them when this request for acceleration has been granted.
Very truly yours,
IBIO, INC.
By:
/s/ Marc A. Banjak
Name:
Marc A. Banjak
Title:
Chief Legal Officer
cc: Leslie Marlow, Blank Rome LLP
Melissa Palat Murawsky, Blank Rome LLP